---
title: "Baker Brothers Life Sciences LP — Ownership Dossier"
canonical: https://whiteintel.dev/entity/e800af18-134e-54b5-92f3-ef6a2fdae609
json: https://whiteintel.dev/api/public/dossier/e800af18-134e-54b5-92f3-ef6a2fdae609
identifier: sec:0001363364
jurisdiction: US
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# Baker Brothers Life Sciences LP

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001363364`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/e800af18-134e-54b5-92f3-ef6a2fdae609  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/e800af18-134e-54b5-92f3-ef6a2fdae609  

## Ownership & control

### Holdings / subsidiaries

- **DBV Technologies S.A.** (10% owner) — https://whiteintel.dev/entity/e833c502-aac4-5f5d-bc9c-03df374f0427
- **Immunocore Holdings plc** (director) — https://whiteintel.dev/entity/5a0803a2-bf07-554e-8b32-43d9a7f4d76c
- **Replimune Group, Inc.** (10% owner) — https://whiteintel.dev/entity/2a9e232f-1c55-5a2d-a5ad-a8f772329c57
- **Replimune Group, Inc.** (10% owner) — https://whiteintel.dev/entity/2a9e232f-1c55-5a2d-a5ad-a8f772329c57
- **BeiGene, Ltd.** (director) — https://whiteintel.dev/entity/f5578d61-5548-5f21-9025-ed125e4ab7ca
- **BICYCLE THERAPEUTICS PLC** (10% owner) — https://whiteintel.dev/entity/0acb5729-b5ad-50bb-a9be-f3ce653d4a67
- **IGM Biosciences, Inc.** (10% owner) — https://whiteintel.dev/entity/3608c469-3b96-5030-8ce2-c1e229f9225f
- **INCYTE CORP** (10% owner) — https://whiteintel.dev/entity/1226ba5b-bd76-5385-89a8-2c29a8a06fcf
- **MADRIGAL PHARMACEUTICALS, INC.** (director) — https://whiteintel.dev/entity/beb6f806-b887-5a50-887a-7da069e8acf2
- **Prelude Therapeutics Inc** (tenpercentowner) — https://whiteintel.dev/entity/7fd405f7-0028-588c-a5fd-53637527e65d
- **Kymera Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/ee121c9c-c882-5afe-93fb-7abe6b4ca8d7
- **Replimune Group, Inc.** (director) — https://whiteintel.dev/entity/2a9e232f-1c55-5a2d-a5ad-a8f772329c57
- **Replimune Group, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/2a9e232f-1c55-5a2d-a5ad-a8f772329c57
- **ACADIA PHARMACEUTICALS INC** (tenpercentowner) — https://whiteintel.dev/entity/e0daead6-1fdc-534a-ae81-4152b4e37d9f
- **Prelude Therapeutics Inc** (director) — https://whiteintel.dev/entity/7fd405f7-0028-588c-a5fd-53637527e65d
- **Kiniksa Pharmaceuticals International, plc** (director) — https://whiteintel.dev/entity/f132a08d-42ce-5d87-a8af-34417927f5a0
- **INCYTE CORP** (tenpercentowner) — https://whiteintel.dev/entity/1226ba5b-bd76-5385-89a8-2c29a8a06fcf
- **Denali Therapeutics Inc.** (director) — https://whiteintel.dev/entity/73626793-468a-5743-a8c0-5b9d1bed32f4
- **TScan Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/ed49fe48-9dbc-5f78-bb8a-f8df134624bb
- **Kymera Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/ee121c9c-c882-5afe-93fb-7abe6b4ca8d7
- **vTv Therapeutics Inc.** (director) — https://whiteintel.dev/entity/353f31f2-6045-5ec1-8144-e0547fb20612
- **ACADIA PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/e0daead6-1fdc-534a-ae81-4152b4e37d9f
- **BeiGene, Ltd.** (director) — https://whiteintel.dev/entity/f5578d61-5548-5f21-9025-ed125e4ab7ca
- **INCYTE CORP** (director) — https://whiteintel.dev/entity/1226ba5b-bd76-5385-89a8-2c29a8a06fcf
- **BICYCLE THERAPEUTICS PLC** (director) — https://whiteintel.dev/entity/0acb5729-b5ad-50bb-a9be-f3ce653d4a67
- **DBV Technologies S.A.** (director) — https://whiteintel.dev/entity/e833c502-aac4-5f5d-bc9c-03df374f0427
- **BICYCLE THERAPEUTICS PLC** (tenpercentowner) — https://whiteintel.dev/entity/0acb5729-b5ad-50bb-a9be-f3ce653d4a67
- **KODIAK SCIENCES INC.** (tenpercentowner) — https://whiteintel.dev/entity/e0b61588-dfb1-55a3-a8c2-ef3087dbcc7a
- **KODIAK SCIENCES INC.** (director) — https://whiteintel.dev/entity/e0b61588-dfb1-55a3-a8c2-ef3087dbcc7a
- **IGM Biosciences, Inc.** (other) — https://whiteintel.dev/entity/3608c469-3b96-5030-8ce2-c1e229f9225f
- **IGM Biosciences, Inc.** (director) — https://whiteintel.dev/entity/3608c469-3b96-5030-8ce2-c1e229f9225f
- **IGM Biosciences, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/3608c469-3b96-5030-8ce2-c1e229f9225f
- **Immunocore Holdings plc** (director) — https://whiteintel.dev/entity/5a0803a2-bf07-554e-8b32-43d9a7f4d76c
- **DBV Technologies S.A.** (tenpercentowner) — https://whiteintel.dev/entity/e833c502-aac4-5f5d-bc9c-03df374f0427
- **BeiGene, Ltd.** (tenpercentowner) — https://whiteintel.dev/entity/f5578d61-5548-5f21-9025-ed125e4ab7ca
- **SEAGEN INC.** (director) — https://whiteintel.dev/entity/c5825089-63d5-5f88-83d5-fd3fc54d96d0
- **SEAGEN INC.** (other) — https://whiteintel.dev/entity/c5825089-63d5-5f88-83d5-fd3fc54d96d0
- **Neurogene Inc.** (other) — https://whiteintel.dev/entity/7be59bde-4b7a-572c-ada1-6fee523070a6
- **Neurogene Inc.** (director) — https://whiteintel.dev/entity/7be59bde-4b7a-572c-ada1-6fee523070a6
- **Neurogene Inc.** (tenpercentowner) — https://whiteintel.dev/entity/7be59bde-4b7a-572c-ada1-6fee523070a6
- **SLIPCHIP CORP** (tenpercentowner) — https://whiteintel.dev/entity/19dd454c-e1b2-58a9-89a2-99cd7cbeb010
- **SEAGEN INC.** (tenpercentowner) — https://whiteintel.dev/entity/c5825089-63d5-5f88-83d5-fd3fc54d96d0
- **SLIPCHIP CORP** (director) — https://whiteintel.dev/entity/19dd454c-e1b2-58a9-89a2-99cd7cbeb010
- **TScan Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/ed49fe48-9dbc-5f78-bb8a-f8df134624bb
- **Spyre Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/bf7dce76-8d4f-5fee-ba09-97415a847c12
- **Kiniksa Pharmaceuticals International, plc** (tenpercentowner) — https://whiteintel.dev/entity/f132a08d-42ce-5d87-a8af-34417927f5a0
- **ALEXION PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/7842a64d-6d8c-59e1-82ea-575c4c24b5fa
- **ZYMEWORKS BC INC.** (director) — https://whiteintel.dev/entity/ec47c47f-283b-5b01-86b5-8c79cd9f2d8a
- **GENOMIC HEALTH INC** (tenpercentowner) — https://whiteintel.dev/entity/2499a431-37e6-5c7a-a147-eaa00d248197
- **GENOMIC HEALTH INC** (director) — https://whiteintel.dev/entity/2499a431-37e6-5c7a-a147-eaa00d248197
- **ACERAGEN, INC.** (tenpercentowner) — https://whiteintel.dev/entity/6856ac9f-9213-5aa5-9a2a-6094683786a7
- **ACERAGEN, INC.** (director) — https://whiteintel.dev/entity/6856ac9f-9213-5aa5-9a2a-6094683786a7
- **XOMA Royalty Corp** (other) — https://whiteintel.dev/entity/879bcb76-24e5-5154-a262-697323c83673
- **SYNAGEVA BIOPHARMA CORP** (director) — https://whiteintel.dev/entity/aabad33f-5398-5580-80ed-e469622973b8
- **SYNAGEVA BIOPHARMA CORP** (tenpercentowner) — https://whiteintel.dev/entity/aabad33f-5398-5580-80ed-e469622973b8
- **SYNAGEVA BIOPHARMA CORP** (other) — https://whiteintel.dev/entity/aabad33f-5398-5580-80ed-e469622973b8
- **MIRATI THERAPEUTICS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/e946aa92-a387-5969-9975-86687d3e9cd3
- **XOMA Royalty Corp** (tenpercentowner) — https://whiteintel.dev/entity/879bcb76-24e5-5154-a262-697323c83673
- **XOMA Royalty Corp** (director) — https://whiteintel.dev/entity/879bcb76-24e5-5154-a262-697323c83673
- **BIOCRYST PHARMACEUTICALS INC** (tenpercentowner) — https://whiteintel.dev/entity/4c2abb17-afd7-5282-930a-5a120a05fb83

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Baker Brothers Life Sciences LP**. Human view: https://whiteintel.dev/entity/e800af18-134e-54b5-92f3-ef6a2fdae609 · Structured JSON: https://whiteintel.dev/api/public/dossier/e800af18-134e-54b5-92f3-ef6a2fdae609._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._